Acadian Asset Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $873K | Sell |
118,211
-1,375
| -1% | -$10.2K | ﹤0.01% | 1006 |
|
|
2025
Q1 | $1.03M | Buy |
+119,586
| New | +$1.03M | ﹤0.01% | 931 |
|
|
2024
Q4 | – | Sell |
-976
| Closed | -$46K | – | 1975 |
|
|
2024
Q3 | $46K | Sell |
976
-1,884
| -66% | -$88.8K | ﹤0.01% | 1814 |
|
|
2024
Q2 | $143K | Sell |
2,860
-15,897
| -85% | -$795K | ﹤0.01% | 1487 |
|
|
2024
Q1 | $2.1M | Buy |
18,757
+11,725
| +167% | +$1.31M | 0.01% | 648 |
|
|
2023
Q4 | $407K | Sell |
7,032
-7,131
| -50% | -$413K | ﹤0.01% | 1072 |
|
|
2023
Q3 | $449K | Buy |
+14,163
| New | +$449K | ﹤0.01% | 1030 |
|
|
2020
Q3 | – | Sell |
-5,154
| Closed | -$3.02M | – | 2292 |
|
|
2020
Q2 | $3.02M | Sell |
5,154
-2,722
| -35% | -$1.59M | 0.01% | 617 |
|
|
2020
Q1 | $1.15M | Buy |
7,876
+2,692
| +52% | +$392K | 0.01% | 752 |
|
|
2019
Q4 | $742K | Buy |
5,184
+1,120
| +28% | +$160K | ﹤0.01% | 962 |
|
|
2019
Q3 | $160K | Buy |
4,064
+2,051
| +102% | +$80.7K | ﹤0.01% | 1374 |
|
|
2019
Q2 | $204K | Buy |
+2,013
| New | +$204K | ﹤0.01% | 1224 |
|
|
2018
Q2 | – | Sell |
-443
| Closed | -$175K | – | 1790 |
|
|
2018
Q1 | $175K | Buy |
+443
| New | +$175K | ﹤0.01% | 1091 |
|